EN-GUIDE-07 · PHARMACEUTICAL AUTOMATION CHANGE

Pharma Automation Change Control: Impact, Validation, Rollback & Quality Release Evidence

A PLC download, SCADA edit, recipe revision, alarm adjustment or server change can alter product, batch, facility, record and recovery behavior at the same time. Fix the operating identity first, assess the full boundary, preserve the approved baseline, execute only the authorized scope and return to use only after objective verification, deviation review and named quality release.

  • Reviewed: 23 July 2026
  • Audience: process · automation · CSV · engineering · quality
  • Output: approved as-left change and release package
Pharmaceutical automation change evidence chain from operating identity and impact boundary through approved baseline, implementation, verification, quality release and as-left handover
Explanatory evidence structure, not a customer system, validation protocol, release value or batch decision.

A successful download is not a validated or released change.

Fix identity. Bound impact. Protect the baseline. Execute the approved scope. Verify intended and unintended behavior. Resolve deviations. Release the named operating state.

No universal test count, alarm limit, process parameter, acceptance value or batch-release rule is implied.

Conditions that require a controlled change boundary

  • A PLC, HMI, SCADA, historian, MES interface, recipe, alarm, network, account, server or infrastructure revision is proposed.
  • A production fault is being “fixed” online while an affected batch, room, utility or record boundary remains unclear.
  • The running application, source project, backup, approved version and as-built field state do not match.
  • A vendor package or cybersecurity update changes services, ports, time, identity, authentication, logging, backup or recovery behavior.
  • The change test proves one intended function but not interlocks, alarms, records, failure behavior, restart or rollback.
  • Implementation completes while deviations, temporary modes, open items or quality release remain outside the handover.

Hold implementation or return to service when any critical boundary is uncontrolled.

Product or batch unclear

Product, batch, material, room, equipment, utility, recipe, process step or quality owner cannot be fixed.

Safety boundary open

Energy, contamination control, interlock, permit, access, automatic action or affected personnel is unresolved.

Baseline not recoverable

Approved source, running version, parameters, data, licenses, certificates, credentials, backup or restore proof is missing.

Impact incomplete

Product, process, facility, utilities, records, interfaces, security, alarm, batch or validation impact is omitted.

Evidence at risk

Original audit trail, electronic record, event, trend, configuration or time provenance may be overwritten or obscured.

Release authority absent

Deviation, failed test, temporary state, rollback decision or named quality approval remains open.

Stop means preserve the approved safe and GMP state.

Maintain the authorized hold, protect raw records and configuration evidence, and return the next decision to the named site authority. This guide does not authorize online edits, access, bypass, energization, contamination-control changes, validation approval or batch release.

Make the change traceable to one operating identity and one approved boundary.

Evidence groupMinimum recordDecision supported
Operating identitySite, product, batch, room, equipment, utility, PLC/HMI/SCADA/MES, recipe, mode, status, time source and ownersFixes the exact operating and quality boundary.
Change requestProblem, intended outcome, requirement, reason, urgency, affected assets, exclusions and approvalsPrevents an undefined “small edit.”
As-found baselineRunning and source versions, checksums, hardware/firmware, settings, accounts, network, field state, backups and restore proofEstablishes what can be compared and recovered.
Impact and riskProduct/batch, CPP/CQA, facility/utility, safety, records, alarm, interface, security, maintenance, training and regulatory impactDefines review depth and evidence owners.
Implementation planAuthorized files, commands, sequence, access, outage, prerequisites, hold points, witnesses, abort and rollbackBounds execution before the first change.
Verification planRequirement traceability, normal/abnormal/restart tests, data capture, expected results, acceptance source and witnessesSeparates evidence from assumption.
Actual executionWho/when/where, files and checksums used, commands, observed responses, deviations and original recordsShows what actually changed.
As-left and releaseFinal versions/settings, backup/restore, open items, temporary states, restrictions, monitoring, batch impact, quality decision and ownersDefines the exact state returned to use.

Keep implementation success separate from GMP release.

Six pharmaceutical automation change gates for identity, impact, baseline and rollback, controlled implementation, verification and deviation review, and quality release with as-left handover
The gates organize evidence and authority; they do not supply validation acceptance values or batch disposition.
GateRequired evidenceNamed output
1. IdentityProduct/batch/room/equipment/utility/system/recipe/status/time and decision owners agree.One fixed operating boundary.
2. ImpactProduct, process, facility, safety, records, interface, security, validation and batch effects are reviewed.Approved scope, exclusions and review depth.
3. Baseline & rollbackAs-found state, approved source, backups, restore method, dependencies, abort triggers and rollback tests are available.Recoverable approved starting state.
4. Controlled implementationAuthorized files, people, access, sequence, hold points, actual actions and independent witnesses are recorded.Traceable executed change.
5. Verification & deviationRequirements, normal/abnormal/restart behavior, alarms, records, interfaces, data integrity and failures are objectively reviewed.Test result plus resolved or controlled deviations.
6. Quality release & as-leftFinal configuration, restore proof, batch/product impact, restrictions, monitoring, open items and named approvals are accepted.Released scope, residual controls and ownership.

Build a reviewable evidence chain before touching the system.

  1. Fix the operating and batch identity.

    Name the product/batch, process step, room, equipment, utilities, automation layers, recipe, mode, event window and decision owners.

  2. Preserve the as-found state and raw records.

    Capture running and source versions, checksums, settings, network/interfaces, accounts, audit trails, alarms, events, trends and field conditions.

  3. Translate the request into approved requirements.

    State the intended outcome, affected functions, exclusions, acceptance-source references and evidence owners without inventing universal criteria.

  4. Assess cross-system and GMP impact.

    Review product, batch, process, facility, utilities, safety, contamination control, records, data integrity, security, training and validation status.

  5. Prove rollback before implementation.

    Verify backups, restore dependencies, licenses/certificates/credentials, data compatibility, abort triggers, safe state and authority to decide rollback.

  6. Execute only the authorized scope.

    Use the approved files and sequence, record actual people/actions/times, stop at hold points and preserve unexpected evidence.

  7. Verify requirements, failure behavior and records.

    Test normal, abnormal, alarm, interlock, interface, restart and recovery paths; compare expected and actual results and control every deviation.

  8. Release and hand over the as-left state.

    Reconcile final versions/settings, restore proof, open items, temporary states, monitoring, batch impact and accountable engineering/CSV/quality acceptance.

Questions before a technically successful change becomes operating authority

  • Does the live system, approved source, as-found evidence and change request describe the same equipment and revision?
  • Can the site explain the product, batch, process, facility, data and validation impact of every changed object?
  • Are audit trails, electronic records and time provenance preserved before any reset, migration or restore?
  • Does rollback include data, interfaces, licenses, certificates, accounts and field state rather than only a project file?
  • Were abnormal, restart, alarm, interlock, interface and record behaviors tested as required by the approved plan?
  • Are deviations, temporary modes, restrictions, monitoring and owners visible to the quality release decision?

Transfer the operating state that actually exists.

Identity and authority

Change ID, product/batch, room/equipment/utility, system/recipe, event window, roles and approvals.

Configuration and evidence

As-found/as-left versions, checksums, backups, settings, audit trails, records, interfaces and physical state.

Verification and impact

Requirement traceability, actual tests, failures, deviations, batch/product review and validation status.

Residual ownership

Temporary states, restrictions, monitoring, open items, rollback readiness, next review and accountable owners.

Use the same evidence chain in change review.

The PDF preserves the gates, collection table, procedure, sources and application limits.

Download the PDF guide

Use each source within its published scope and jurisdiction.

Application limits

FDA guidance and eCFR describe United States regulatory or guidance scope; EudraLex Volume 4 describes European Union GMP legislation and guidance; NIST SP 800-82 is OT security guidance. They are not interchangeable national rules, site validation protocols, universal alarm or process values, or batch-release authority. Confirm current country and product requirements, marketing authorization, pharmacopoeia, AHJ, site quality system, approved SOPs, validation/qualification strategy, permits, OEM requirements, qualified personnel and named quality authority.

Connect the change procedure to broader capability and shared evidence language.